🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
IMC
$IMCR
🔒 US EquitiesImmunocore Holdings plc
AVG HISTORICAL GAP
+0.58%
MAX GAP RECORD
+6.79%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $IMCR
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$IMCR
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN) |
-1.35%
|
| May 06, 2026 Earnings Release 2026-05-06 (BEFORE OPEN) |
+3.43%
|
| Feb 25, 2026 Earnings Release 2026-02-25 (BEFORE OPEN) |
-3.50%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
+0.91%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
+0.16%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+6.74%
|
| Feb 26, 2025 Earnings Release 2025-02-26 (BEFORE OPEN) |
-4.14%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.8%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (5)
📖 Intelligence Summary
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. the firm's lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma,…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗